AQUEOUS SOLUTION;
ARTICLE;
CATALYSIS;
DRUG ANTAGONISM;
DRUG FORMULATION;
DRUG METABOLISM;
DRUG STABILITY;
DRUG STRUCTURE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
IN VITRO STUDY;
METABOLITE;
PH;
PRIORITY JOURNAL;
QUANTITATIVE STUDY;
SOLID STATE;
TEMPERATURE SENSITIVITY;
Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine in mice
DOI 10.1158/1078-0432.CCR-06-1250
JH Beumer JL Eiseman RA Parise E Joseph JL Holleran JM Covey, et al. 2006 Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine in mice Clin Cancer Res 12 7483 7491 10.1158/1078-0432.CCR-06-1250 1:CAS:528:DC%2BD28XhtlCrtrzF 17138702 (Pubitemid 46095424)
Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2′- deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU)
DOI 10.1007/s00280-007-0603-8
JH Beumer RA Parise EM Newman JH Doroshow TW Synold H-J Lenz, et al. 2008 Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2′- deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU) Cancer Chemother Pharmacol 62 363 368 10.1007/s00280-007-0603-8 1:CAS:528:DC%2BD1cXlvVWitbk%3D 17899082 (Pubitemid 351692084)
Analysis of cytidine deaminase and tetrahydrouridine interaction by use of ligand techniques
DOI 10.1016/0006-2952(78)90256-3
RG Stoller CE Myers BA Chabner 1978 Analysis of cytidine deaminase and tetrahydrouridine interaction by use of ligand techniques Biochem Pharmacol 27 53 59 10.1016/0006-2952(78)90256-3 1:CAS:528:DyaE1cXhtlams70%3D 619907 (Pubitemid 8239568)
Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma
DA Boothman TV Briggle S Greer 1987 Tumor-selective metabolism of 5-fluoro-2′-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma Cancer Res 47 2354 2362 1:CAS:528:DyaL2sXksFWnu7w%3D 2952263 (Pubitemid 17099196)
Epimer interconversion, isomerization, and hydrolysis of tetrahydrouridine: Implications for cytidine deaminase inhibition
DOI 10.1002/jps.10447
T Xiang R Niemi P Bummer BD Anderson 2003 Epimer interconversion, isomerization, and hydrolysis of tetrahydrouridine: implications for cytidine deaminase inhibition J Pharma Sci 92 2027 2039 10.1002/jps.10447 1:CAS:528:DC%2BD3sXnvFOms7o%3D (Pubitemid 37175633)